Cryo-Cell Processed Cord Blood Unit
Hematologic malignancies, bone marrow failure, metabolic & immune disorders (via HSC transplant)
CommercialActive - Banked and available for use
Key Facts
Indication
Hematologic malignancies, bone marrow failure, metabolic & immune disorders (via HSC transplant)
Phase
Commercial
Status
Active - Banked and available for use
Company
About Cryo-Cell
Cryo-Cell International is a pioneer and established commercial leader in the family cord blood banking industry, founded in 1989. The company's core business is the cryopreservation and storage of hematopoietic stem cells derived from umbilical cord blood, offering families a form of biological insurance. While its primary revenue is generated from storage services, Cryo-Cell also engages in research and development related to cellular therapies. The company faces a competitive landscape but maintains a strong brand and a large existing client base.
View full company profile